Results 61 to 70 of about 20,294,267 (243)
Improving the Gilbert-Varshamov bound for $q$-ary codes [PDF]
Discrete Mathematics & Theoretical Computer Science, 2005 Given positive integers $q$, $n$ and $d$, denote by $A_q(n,d)$ the maximum size of a $q$-ary code of length $n$ and minimum distance $d$. The famous Gilbert-Varshamov bound asserts that $A_q(n,d+1) \geq q^n / V_q(n,d)$, where $V_q(n,d)=\sum_{i=0}^d ...Van H. Vu, Lei Wudoaj +1 more sourcePrognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio‐Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse
Pediatric Blood &Cancer, EarlyView.ABSTRACT Introduction
Neuroblastoma (NB) with central nervous system (CNS) metastases is rare at diagnosis, but occurs more often during relapse/progression. Patients with CNS metastases face a dismal prognosis, with no standardized curative treatment available.Vicente Santa‐Maria Lopez, Anna Felip‐Badia, Marina Caballero‐Bellon, Nazaret Sanchez‐Sierra, Alicia Castañeda, Moira Garraus, Maite Gorostegui, Margarida Simão‐Rafael, Juan Pablo Muñoz, Marta Perez‐Somarriba, Salvador Mañe, Mariana Cecilia Planells, Sara Perez‐Jaume, Jaume Mora +13 morewiley +1 more sourcePathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing Sarcoma
Pediatric Blood &Cancer, EarlyView.ABSTRACT
Approximately 10% of patients with Ewing sarcoma (EwS) have pathogenic germline variants. Here, we report two cases: first, a novel germline pathogenic variant in partner and localizer of BRCA2 (PALB2) in a patient with a late EwS relapse. Its impact on homologous recombination is demonstrated, and breast cancer risk is discussed.Molly Mack, A. Carolina Tufino, Mohd Azrin Jamalruddin, Sreya Dey, Yinghong Pan, Elina Mukherjee, Jessica D. Daley, Julia Meade, Mahmoud Aarabi, Lisa Maurer, James Cooper, Kara A. Bernstein, Kelly M. Bailey +12 morewiley +1 more sourceThe Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
Aging Cell, 2015 The healthspan of mice is enhanced by killing senescent cells using a transgenic suicide gene. Achieving the same using small molecules would have a tremendous impact on quality of life and the burden of age‐related chronic diseases.Yi Zhu, T. Tchkonia, T. Pirtskhalava, A. Gower, H. Ding, N. Giorgadze, Allyson K. Palmer, Y. Ikeno, G. Hubbard, M. Lenburg, S. O’Hara, N. LaRusso, Jordan D. Miller, Carolyn M. Roos, Grace C. Verzosa, N. LeBrasseur, J. Wren, J. Farr, S. Khosla, Michael B. Stout, S. McGowan, Heike Fuhrmann-Stroissnigg, Aditi U. Gurkar, J. Zhao, D. Colangelo, A. Dorronsoro, Y. Ling, Amira S Barghouthy, D. C. Navarro, T. Sano, P. Robbins, L. Niedernhofer, J. Kirkland +32 moresemanticscholar +1 more sourceThe IceCube Neutrino Observatory: Instrumentation and Online Systems [PDF]
, 2016 The IceCube Neutrino Observatory is a cubic-kilometer-scale high-energy neutrino detector built into the ice at the South Pole. Construction of IceCube, the largest neutrino detector built to date, was completed in 2011 and enabled the discovery of high ...I. C. M. Aartsen, M. Ackermann, J. Adams, J. Aguilar, M. Ahlers, M. Ahrens, D. Altmann, K. Andeen, T. Anderson, I. Ansseau, G. Anton, M. Archinger, C. Arguelles, R. Auer, J. Auffenberg, S. Axani, J. Baccus, X. Bai, S. Barnet, S. Barwick, V. Baum, R. Bay, K. Beattie, J. Beatty, J. Tjus, K. Becker, T. Bendfelt, S. Benzvi, D. Berley, E. Bernardini, A. Bernhard, D. Besson, G. Binder, D. Bindig, M. Bissok, E. Blaufuss, S. Blot, D. Boersma, C. Bohm, M. Borner, F. Bos, D. Bose, S. Boser, O. Botner, A. Bouchta, J. Braun, L. Brayeur, H. Bretz, S. Bron, A. Burgman, C. Burreson, T. Carver, M. Casier, E. Cheung, D. Chirkin, A. Christov, K. Clark, L. Classen, S. Coenders, G. Collin, J. Conrad, D. Cowen, R. Cross, C. Day, M. Day, J. Andr'e, C. Clercq, E. del Pino Rosendo, H. Dembinski, S. Ridder, F. Descamps, P. Desiati, K. D. Vries, G. Wasseige, M. With, T. DeYoung, J. C. D'iaz-V'elez, V. Lorenzo, H. Dujmovic, J. Dumm, M. Dunkman, B. Eberhardt, W. Edwards, T. Ehrhardt, B. Eichmann, P. Eller, S. Euler, P. Evenson, S. Fahey, A. Fazely, J. Feintzeig, J. Felde, K. Filimonov, C. Finley, S. Flis, C.-C. Fosig, A. Franckowiak, M. Frere, E. Friedman, T. Fuchs, T. Gaisser, J. Gallagher, L. Gerhardt, K. Ghorbani, W. Giang, L. Gladstone, T. Glauch, D. Glowacki, T. Glusenkamp, A. Goldschmidt, J. G. Gonzalez, D. Grant, Z. Griffith, L. Gustafsson, C. Haack, A. Hallgren, F. Halzen, E. Hansen, T. Hansmann, K. Hanson, J. Haugen, D. Hebecker, D. Heereman, K. Helbing, R. Hellauer, R. Heller, S. Hickford, J. Hignight, G. Hill, K. Hoffman, R. Hoffmann, K. Hoshina, F. Huang, M. Huber, P. Hulth, K. Hultqvist, S. In, M. Inaba, A. Ishihara, E. Jacobi, J. Jacobsen, G. Japaridze, M. Jeong, K. Jero, A. Jones, B. Jones, J. Joseph, W. Kang, A. Kappes, T. Karg, A. Karle, U. Katz, M. Kauer, A. Keivani, J. Kelley, J. Kemp, A. Kheirandish, J. Kim, M. Kim, T. Kintscher, J. Kiryluk, N. Kitamura, T. Kittler, S. Klein, S. Kleinfelder, M. Kleist, G. Kohnen, R. Koirala, H. Kolanoski, R. Konietz, L. Kopke, C. Kopper, S. Kopper, D. Koskinen, M. Kowalski, M. Krasberg, K. Krings, M. Kroll, G. Kruckl, C. Kruger, J. Kunnen, S. Kunwar, N. Kurahashi, T. Kuwabara, M. Labare, K. Laihem, H. Landsman, J. Lanfranchi, M. Larson, F. Lauber, A. Laundrie, D. Lennarz, H. Leich, M. Lesiak-Bzdak, M. Leuermann, L. Lu, J. Ludwig, J. Lunemann, C. Mackenzie, J. Madsen, G. Maggi, K. Mahn, S. Mancina, M. Mandelartz, R. Maruyama, K. Mase, H. Matis, R. Maunu, F. McNally, C. Mcparland, P. Meade, K. Meagher, M. Medici, M. Meier, A. Meli, T. Menne, G. Merino, T. Meures, S. Miarecki, R. Minor, T. Montaruli, M. Moulai, T. Murray, R. Nahnhauer, U. Naumann, G. Neer, M. Newcomb, H. Niederhausen, S. Nowicki, D. Nygren, A. Pollmann, A. Olivas, A. O'Murchadha, T. Palczewski, H. Pandya, D. Pankova, S. Patton, P. Peiffer, O. Penek, J. Pepper, C. Heros, C. Pettersen, D. Pieloth, E. Pinat, P. Price, G. Przybylski, M. Quinnan, C. Raab, L. Radel, M. Rameez, K. Rawlins, R. Reimann, B. Relethford, M. Relich, E. Resconi, W. Rhode, M. Richman, B. Riedel, S. Robertson, M. Rongen, C. Roucelle, C. Rott, T. Ruhe, D. Ryckbosch, D. Rysewyk, L. Sabbatini, S. Herrera, A. Sandrock, J. Sandroos, P. Sandstrom, S. Sarkar, K. Satalecka, P. Schlunder, T. Schmidt, S. Schoenen, S. Schoneberg, A. Schukraft, L. Schumacher, D. Seckel, S. Seunarine, M. Solarz, D. Soldin, M. Song, G. Spiczak, C. Spiering, T. Stanev, Alexander Stasik, J. Stettner, A. Steuer, T. Stezelberger, R. Stokstad, A. Stossl, R. Strom, N. Strotjohann, K. Sulanke, G. Sullivan, M. Sutherland, H. Taavola, I. Taboada, J. Tatar, F. Tenholt, S. Ter-Antonyan, A. Terliuk, G. Tevsi'c, L. Thollander, S. Tilav, P. Toale, M. Tobin, S. Toscano, D. Tosi, M. Tselengidou, A. Turcati, E. Unger, M. Usner, J. Vandenbroucke, N. Eijndhoven, S. Vanheule, M. Rossem, J. Santen, M. Vehring, M. Voge, E. Vogel, M. Vraeghe, D. Wahl, C. Walck, A. Wallace, M. Wallraff, N. Wandkowsky, C. Weaver, M. Weiss, C. Wendt, S. Westerhoff, D. Wharton, B. Whelan, S. Wickmann, K. Wiebe, C. Wiebusch, L. Wille, D. Williams, L. Wills, P. Wisniewski, M. Wolf, T. R. Wood, E. Woolsey, K. Woschnagg, D. Xu, X. Xu, Y. Xu, J. Yáñez, G. Yodh, S. Yoshida, M. Zoll +351 moresemanticscholar +1 more sourceImproved Outcomes for Older Children, Adolescents, and Young Adults With Neuroblastoma in the Post‐Immunotherapy Era: An Updated Report From the International Neuroblastoma Risk Group
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background
We describe clinical and biologic characteristics of neuroblastoma in older children, adolescents, and young adults (OCAYA); describe survival outcomes in the post‐immunotherapy era; and identify if there is an age cut‐off that best discriminates outcomes.Rebecca J. Deyell, Kavitha Srivatsa, Paola Angelini, Pei‐Chi Kao, Brady Payne, Arlene Naranjo, Sveva Castelli, Miho Kato, Miki Ohira, Ulriche Pöetschger, Yaël Mossé, Lucas Moreno, Meredith S. Irwin, Ramya Ramanujachar, Wendy B. London +14 morewiley +1 more sourceDevelopmental Disorders in Children Recently Diagnosed With Cancer
Pediatric Blood &Cancer, EarlyView.ABSTRACT
Neurocognitive deficits in adult survivors of childhood cancer are well established, but less is known about developmental disorders (DD) arising shortly after cancer diagnosis. Using 2016–2019 linked Ohio cancer registry and Medicaid data, we compared DD among 324 children with cancer and 606,913 cancer‐free controls.Jamie Shoag, Long Vu, Ritika Miryala, Jeffrey M. Albert, Molly McVoy, Siran M. Koroukian +5 morewiley +1 more sourceDivisão do gênero Distenia Lepeletier & Audinet-Serville, notas sobre a venação alar em Disteniini, Homonímias, Sinonímia e Redescrições (Coleoptera, Cerambycidae, Disteniinae)
Papéis Avulsos de Zoologia, 2007 Divisão do gênero Distenia Lepeletier & Audinet-Serville, notas sobre a venação alar em Disteniini, homonímias, sinonímia e redescrições (Coleoptera, Cerambycidae, Disteniinae). O gênero Distenia é dividido em cinco gêneros: Hovorestenia Santos-Silva gen.Antonio Santos-Silva, Frank T. Hovoredoaj +1 more sourceCharacterizing Parental Concerns About Lasting Impacts of Treatment in Children With B‐Acute Lymphoblastic Leukemia
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background
B‐acute lymphoblastic leukemia (B‐ALL) is the most common pediatric cancer, and while most children in high‐resource settings are cured, therapy carries risks for long‐term toxicities. Understanding parents’ concerns about these late effects is essential to guide anticipatory support and inform evolving therapeutic approaches ...Kellee N. Parker, Sarah W. Alexander, Lisa M. Jacola, Kimberly A. Buff, Kyobin Hwang, Elham Hashemi, Gregory Stoddard, Lindsay A. Jibb +7 morewiley +1 more source
